Ehrlich Leo

CEO and Chairman, DirectorInnovation Pharmaceuticals Inc. (IPIX) · full profile →Form 4 · filed Sep 28, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
13
2 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2020Tax withholding(F)7.8M$0.21$1.6M0
Feb 23, 2020Grant(A)500K$07.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 10, 2021Grant(A)1.0M$01.0M
Dec 28, 2020Tax withholding(F)1.8M$0.21$371K15.6M
Dec 28, 2020Option exercise(M)13.1M$0.11$1.4M17.4M
Dec 28, 2020Option exercise(M)13.1M$00
Oct 2, 2020Option exercise(M)909K$0.11$100K4.5M
Oct 2, 2020Tax withholding(F)181K$0.22$40K4.3M
Oct 2, 2020Option exercise(M)909K$013.1M
Sep 8, 2020Tax withholding(F)412K$0.22$91K3.6M
Sep 8, 2020Option exercise(M)2.2M$0.11$242K4.0M
Sep 8, 2020Option exercise(M)2.2M$014.0M
Feb 23, 2020Grant(A)500K$0500K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-22-007272) within minutes of acceptance. Every field above traces to the original document. Verify it directly: